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Phenotype of three consanguineous Tunisian
families with early-onset retinal degeneration
caused by an R91W homozygous mutation
in the RPE65 gene
Abstract Purpose: To identify the
genetic defect and to phenotype
three consanguineous Tunisian
families presenting with early-onset
retinal degeneration (EORD).
Methods: All accessible family
members were included. They
underwent blood sampling and
ophthalmological examination
including, when possible, full-field
ERG and pupillometry. A genome-
wide linkage analysis was initiated.
Mutation analysis of the RPE65 gene
within the linked interval was per-
formed by bi-directional sequencing.
Results: Eleven out of 53 examined
members were clinically affected
with an EORD. Linkage analysis
revealed a maximal lod score of 4.02
(θ=0.1) for the marker D1S207 on
1p31. Mutational screening of the
RPE65 gene identified a homozy-
gous R91W mutation co-segregating
with the disease in all affected
individuals. Eleven homozygotes had
nystagmus and acuities ranging from
CF to NLP. Two retinal patterns were
identified: pattern 1 presented mid-
peripheral deep white dot deposits
and virtually no clumped pigmenta-
tion, whereas pattern 2 showed mid-
peripheral pigmented clumps without
any white deposits. Homozygotes
had no detectable full-field ERG and
an abnormal pupillary light reflex.
Eleven heterozygotes had normal
visual function. Conclusion: We
identified and characterised an endem-
ic form of early onset rod-cone dystro-
phy in a consanguineous population
from northeastern Tunisia, due to the
prevalence of a single RPE65 muta-
tion. Two funduscopic patterns were
identified: white dot deposits in ear-
lier stages and clumped pigment in
later stages.
Introduction
Early-onset retinal dystrophy (EORD) includes heteroge-
neous hereditary disorders sharing degeneration of both rod
and cone photoreceptors [10]. At the most severe end of the
spectrum of EORD and accounting for 5% of all retinal
dystrophies is Leber congenital amaurosis; a less aggres-
sive form is juvenile retinitis pigmentosa [6, 9, 25].
Among the different genes that have been identified to
account for EORD, mutations in the RPE65 gene seem to
be the most frequent [3, 12, 25, 30] (approximately 6%)
[9]. The RPE65 gene has been assigned to chromosome
1p31 [7] and encodes for a retinal pigment epithelium-
specific and highly conserved abundant 65-kDa protein.
This protein is a retinol ester-binding protein that plays an
important role in the vitamin A cycle, being necessary for
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the conversion to 11-cis retinal [7], the chromophore of the
visual pigments.1
Mice and dogs lacking RPE65 gene (knock-out model)
have been developed and studied [22, 28]. Histopathologic
examinations of the diseased eyes from these animal
models have revealed decreased accumulation of lipofuscin
[11] and increased accumulation of retinyl esters in the
RPE [16]. Partial functional and structural recovery of the
retina after gene therapy in the RPE65 null mutation dog
was recently reported [19].
The human molecular pathology of the RPE65 gene is
not fully described and little is known regarding genotype/
phenotype correlations and natural history of specific
disease-causing mutations [3, 5, 8, 20, 21, 25].
In this study three families harbouring a single RPE65
mutation were fully characterised, as precise phenotyping
is likely to represent an important prerequisite for future
trial of gene therapy.
Patients and methods
Fifty-three members of three consanguineous nuclear
families (Fig. 1) with EORDwho originated from the same
village in Cap Bon, northeastern Tunisia were included in
the study. They underwent complete ophthalmological
examination and, when possible, fluorescein angiography,
colour vision test, computerised visual field, full-field
ERG and pupillometry.
Fig. 1 a Pedigree BH. b Pedigree BO. Filled symbols denote
individuals RPE65R91W/R91W; symbols with dots represent indivi-
duals RPE65WT/R91W; W open symbols show wild-type unaffected
individuals RPE65WT/WT; N open symbols represent the non-
genotyped members with normal phenotype; plain open symbols are
the non-examined members
1Moiseyev et al identified the RPE65 protein as the isomerohy-
drolase transforming all-trans retinyl-ester into 11-cis retinol.
Moiseyev G, Chen Y, Takahashi Y, Wu BX, Ma JX. RPE65 is the
isomerohydrolase in the retinoid visual cycle. Proc Natl Acad Sci
U S A. 2005 Aug 30;102(35):12413–12418
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With their consent, blood samples were obtained from
26 family members.
Clinical and electrophysiological examinations
Visual acuities were tested with Snellen chart and illiterate
E chart. Computerised visual fields were measured with
Humphrey Systems (Program 30–3, Humphrey Field
Analyzer II, San Leandro, CA, USA). Colour vision was
tested using the Farnsworth D-15 saturated dichotomous
test. Presence of nystagmus was evaluated. The anterior
segment was examined with a slit lamp (Haag–Streit), and
fundoscopy was performed by binocular indirect ophthal-
moscopy. Fundus photographs and fluorescein angiogra-
phy were performed with a fundus camera (Topcon). The
electroretinography was performed under topical anaes-
thetic (tetracaine monodoses) using an ERG unit (Veritas;
LKC, Gaithersburg, USA) according to the ISCEV stan-
dards (International Society for Clinical Electrophysiology
of Vision). Pupillometry was carried out using a prototype
portable pupillometry device (Neuroptics, Irvine, CA, USA).
The device gave a 1-s diffuse light stimulus to one eye
(6.2 mW/cm2) while recording the iris and pupillary mar-
gins continuously for 1 s after the light stimulus. Internal
software analysis automatically calculated the maximum
area, minimum area, percentage of contraction amplitude,
latency and velocity. Normative data based on age and
baseline pupil size were provided by the manufacturer. Five
measurements of the pupil light reflex per eye were
obtained and averaged to minimise confounding effects
from short-term variability.
Molecular analysis
Genomic DNA was isolated from peripheral blood
leucocytes as described elsewhere [15]. Genotyping was
performed using 396 fluorescent dye-labeled dinucleotide
repeat markers –FAM, _HEX or NED (Prism Linkage
Mapping Set, Version 2; Applied Biosystems) following
instructions from the manufacturer. PCR products were
pooled and denatured at 90°C for 2 min. Markers were
electrophoresed on denaturing polyacrylamide Performance
Optimized Polymer 4 gels (POP-4; Applied Biosystems) on
an automatic DNA sequencer (ABI-Prism 310 Genetic
Analyser). Data were collected and analysed using Genes-
can and Genotyper software packages. Linkage analysis
was performed with MLINK using equal allele frequency
and a new mutation rate of 10–4.
Once linkage had been established, each of the exons
of the best candidate gene was amplified by PCR as
previously described. The PCR products were then
screened for mutations by single-strand conformational
polymorphism (SSCP) analysis. The abnormal conform-
ers were sequenced bidirectionally.
Results
The three nuclear families belonging to two distinct pedigrees
(BH and BO) are shown in Fig. 1. Eleven of the 53 examined
family members were clinically affected with EORD. Blood
samples were obtained from 10 of them and from 16
unaffected family members. Linkage analysis revealed a
maximal lod score of 4.02 (θ =0.1) for marker D1S207 on
chromosome 1p31, mapping close to the RPE65 gene locus.
Mutational analysis of the RPE65 gene identified a homo-
zygous R91W missense mutation (CGG to TGG) in exon 4
(Fig. 2c), co-segregating with the disease in all affected
individuals. Analysis of the blood samples from the 16
clinically unaffected members revealed 12 heterozygotes
RPE65WT/R91W and 4 wild-type RPE65WT/WT (Fig. 2a,b).
Details of the ten examined homozygotes are summarised
in Table 1. None had signs of syndrome-associated features.
They all had congenital night blindness and no photophobia.
They had useful vision in the first decade of life, allowing
reading acquisition, but had to learn Braille at the end of the
first decade. They progressively lost vision in the third decade
of life to the point of disability. They were aged 19–55 years
Fig. 2 Genomic sequences: missense mutation R91W (CGG to TGG) in exon 4 of the RPE65 gene. a Wild-type missense mutation
RPE65WT/WT. b Heterozygotes mutation RPE65WT/R91W. c Homozygotes RPE65R91W/R91W
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Table 1 Details of homozygous individuals
Patient/
age
(years)/
sex
Acuity
(ETDRS)
Ambulatory
vision,
up to
Refraction Lens Macula Disk Peripheral
pigment
clumps
Retinal
vessels
Fluorescein
angiography
Pattern
Pedigree BH
Patient
IV:
2/55/F
BE:LP No,
50 years
NA APoNSPCOcat Atrophic Slight
pallor
++ Attenuated NA 2
Patient
IV:
3/49/M
BE:LP No,
21 years
RE: S
+3.00,
C–3.75
LE:S-1.5,
C–3.00
NSPCOcat Atrophic,
RPE
changes
Slight
pallor
++ Attenuated Confluent lobular
macular choriretinal
filling defect
hypofluorescence,
central and
peripheral pigment
clumps blockage
hypofluorescence
2
Patient
V:
3/54/F
BE:LP No,
47 years
NA NSPCOcat Atrophic,
RPE
changes
Pale + Attenuated NA 2
Patient
V:
7/43/M
BE:NLP No,
30 years
RE: S+
2.25,
C–1.5
LE:S+5.5,
C–2.00
PCOcat Atrophic Pale (+) Attenuated NA 2
Patient
V:
10/38/
F
RE: CF
LE: HM
No,
30 years
NA PCOcat Atrophic,
sparse
RPE
changes
Slight
pallor
(+), mid-pe-
ripheral
white dot
deposits
Attenuated NA 1
Pedigree BO
Patient
IV:
5/43/M
BE: LP No, 22
years
RE:S–8.75,
C–2.5
LE: S–7.00,
C–0.75
APoPCOcat Atrophic Slight
pallor
++ Attenuated Lobular partial
confluent
hypofluorescence
2
Patient
IV:
9/41/M
RE: LP
LE:NLP
No,
32 years
RE: S–1.25,
C–0.5
LE:S+0.75,
C–2.5
PCOcat Atrophic Slight
pallor
+++ Attenuated NA 2
Patient
IV:
10/36/
M
BE: LP Yes RE:S–7.5,
C–1.00
LE:S–7.5,
C–3.25
PCOcat Atrophic Slight
pallor
++ Attenuated Mid-peripheral
confluent lobular
hypofluorescence
2
Patient
IV:
12/32/
F
RE: CF
LE: LP
Yes NA None Atrophic Slight
pallor
Absent Attenuated NA 1
Patient
V:
7/19/F
BE: CF Yes RE:S–6.5,
C–3.5
LE:S–10.5,
C–2.0
PCOcat RPE
mottling
Healthy Absent,
mid-
peripheral
white dots
Normal Early macular
hypofluorescence
due to CMO with
late pooling, early
peripheral hypo-
fluorescence, late
mottled hyper-
fluorescence
1
Po, polar; PCO, posterior capsular opacity; A, anterior; P, posterior; NS, nuclear sclerosis; cat, cataract
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with visual acuities ranging from CF to NLP. All had con-
genital nystagmus decreasing with age. There was no trend
towards specific refraction default. All had brown irides and
all but one had posterior capsular cataract. Bilateral anterior
polar cataract was found in two patients.
Patient V:14, pedigree BO, a 19-year-old myopic female
with uncorrected distance visual acuity of CF, had a blue–
yellow axis on the Farnsworth dichotomous D-15 test and the
Humphrey visual field showed a partial island of central
vision in the left eye. Patient V:10/38/F, pedigree BH, and
patient IV:12/32/F, pedigree BO, were not able to perform
either the Farnsworth dichotomous D-15 or the Humphrey
visual field tests but could distinguish saturated red, blue, and
green colours and showed very restricted confrontational
Table 2 Funduscopy and fluorescein angiography findings
Pattern Fundus colour photography Fluorescein angiography
Pattern 1 (n=3) 1. Healthy disk 1. Macula: early hypofluorescence probably due to foveal cysts
2. Macular RPE changes or cystoid macular oedema 2. Periphery: early hypofluorescence due to late filling of the
inner choroid with late irregular fluorescence due irregular
dying away RPE.
3. Normal or slightly attenuated retinal vessels
4. Peripheral grey discoloration of the retina and white
dot deposits with virtually no clumped pigmentations
Pattern 2 (n=7) 1. Pale disc 1. Macula: Large partially confluent lobular area of
hypofluorescence in early and late frames due respectively
to absence of the inner choroid and cystoid macular oedema
2. Macular atrophy 2. Periphery: annular patches masking the normal background
fluorescence corresponding to clumped pigmentations
3. Attenuated vessels
4. Clumped pigmentation
Fig. 3 Pattern 1: fundus colour photography and fluorescein an-
giography. a. Fundus colour photograph, right eye. Patient V:7/19/F,
pedigree BO. Confluent white dot deposits and grey discoloration of
the RPE localised outside the temporal vascular arcades. Peripap-
illary atrophy. b. Fluorescein angiogram, early frame, right eye.
Patient V:7/19/F, pedigree BO. Mid-peripheral hypofluorescence
caused by diffuse alteration of the RPE and lack of the choriocap-
illaris. Cystoid hypofluorescence in the macular area due to cystoid
macular oedema. c. Fundus colour photograph, left eye. Patient
V:7/19/F, pedigree BO. As in (a). d. Fluorescein angiogram, late
frame, left eye. Patient V:7/19/F, pedigree BO. Persistence of mid-
peripheral diffuse hypofluorescence and well-delimited islands of
hyperfluorescence in the posterior pole and outside the temporal
vascular arcades corresponding to the area of white dot deposits and
grey discoloration of the RPE demonstrated in (a) and (c). Petaloid
hypofluorescence in the macular area due to cystoid macular
oedema
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visual fields. For the others, both colour vision and visual
field were not testable.
Fundus and fluorescein angiography findings were
subdivided into two patterns (Table 2). Pattern 1 included
relative vascular and disc preservation, mid-peripheral
deep white dot deposits, grey coloration of the peripheral
retina and virtually no clumped pigmentations. Angiogra-
phy (n=1) showed peripheral hypofluorescence in early
and late frames due to lack of choriocapillaris, mid-
peripheral hyperfluorescence increasing during the transit,
reflecting an unhealthy EP, and partial preservation of the
choriocapillaris. Hypofluorescence of the macular area
may have been due to cystoid macular oedema (Fig. 3).
Pattern 2 included attenuated vessels and optic disc pallor,
mid-peripheral clumped pigmentation and absence of
white dots. Angiography (n=3) showed a lack of chorio-
capillaris in the periphery as well as in the posterior pole.
Peripheral and central masking in the zone corresponding
to clumped pigment (Fig. 4) .The mean age in pattern 1 was
29±12.02 years and in pattern 2, 47±5.45 years (p=0.03).
Patients in pattern 1 had better vision then pattern 2 (NS)
(Table 1).
Eleven of the 13 diagnosed heterozygotes were assessed.
They were aged 34–86 years. All had normal vision, rang-
ing from 20/50 to 20/20, except one (patient III: 1/65/F,
pedigree BO) who was diabetic and had high myopia and
age-related cataract (visual acuity OU 20/200). All had
normal confrontational visual fields and none had nystag-
mus. Funduscopy was normal.
Both scotopic and photopic ERG responses were not
detectable in the 8 homozygotes tested. ERG responses
were normal in the two heterozygotes tested.
Pupillometry was performed in nine homozygotes, three
heterozygotes and two wild-type controls. The controls
showed normal contraction amplitude, velocity and laten-
cy. The pupil data of three members of the pedigree BH
(patients V:7, V:3, IV:2) were excluded because inadequate
numbers of reliable samples (fewer than five) were
Fig. 4 Pattern 2: fundus colour photography and fluorescein
angiography. a Composed fundus colour photograph, right eye.
Patient IV:3/49/M, pedigree BH. Typical mid-peripheral pigmented
clumps of different sizes either entirely pigmented or with central
depigmentation. b Fluorescein angiogram, late frame, right eye.
Patient IV:3/49/M, pedigree BH. Posterior pole confluent hypo-
fluorescence due to alteration of the RPE and lack of the
choriocapillaris in the macular area. Masking effect at the posterior
pole and mid-periphery due to clumped pigmentation. c Composed
fundus colour photograph, left eye. Patient IV:2/55/F, pedigree BH.
Typical mid-peripheral pigmented clumps of different sizes either
entirely pigmented or with central depigmentation. Blurred view of
the posterior pole due to lens opacities
Table 3 Pupillometry results in pedigrees BH and BO
Patient/ age (years)/sex Contraction amplitude (CA) Latency (LAT) Contraction velocity (V) RPE65: R91W
mutation,
WT wild type
CA RE CA LE LAT RE LAT LE V RE V LE
Pedigree BH
Patient V:3/54/F 0.01* NR NR NR NR NR R91W/R91W
Patient V:10/38/F 0.49* 0.70* 0.47* 0.31* 0.59* 0.65* R91W/R91W
Patient IV:4/40/F 1.12 1.24 0.23 0.23 1.68 2.11 WT/R91W
Pedigree BO
Patient III:1/65/F 1.13 0.99 0.26* 0.26* 1.64 1.79 WT/R91W
Patient IV:5/43/M 0.63* 0.72* NR 0.49* NR 1.34* R91W/R91W
Patient IV:11/34/F 1.18 1.19 0.24 0.23 1.65 1.83 WT/R91W
Patient IV:12/32/F 1.13 0.89 0.28* 0.28* 1.56 1.47 R91W/R91W
Patient V:7/19/F 0.59* 0.54* 0.31* 0.42* 0.73* 0.60* R91W/R91W
*Beyond one standard deviation
*Normal ranges: contraction amplitude 0.81–1.97; latency ≤ 0.25; contraction velocity ≥ 1.44
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obtained due to nystagmus. Pupillary responses of the 8
other family members (5 homozygotes, 3 heterozygotes)
are reported in Table 3. Waveforms of an heterozygote
(pedigree BO: patient IV.11) and an homozygote (pedigree
BH: patient IV:3) are shown in Fig. 5. Patient V:3/54/F,
pedigree BH, showed recordable responses only in the
contraction amplitude in the right eye, allowing no further
conclusions. Evaluation of the pupillary light reflex re-
vealed diminished contraction amplitude, prolonged latency
time and decreased contraction velocity in three homo-
zygotes with poor vision (two of pattern 1, one of pattern 2).
One additional homozygote with visual acuity of CF RE and
LP LE (patient IV:12/32/F, pedigree BO, pattern 1) had a
subnormal contraction amplitude with only minimal pro-
longation of the pupillary latency time. Pupillometry was
normal in two heterozygotes, and a third heterozygote
(patient III:1/65/F, pedigree BO) who was also diabetic
showed a mildly prolonged latency time.
Discussion
RPE65 mutations are a common cause of EORD [14] and
may be responsible in 6.1–11.4% of patients with
mutations in homozygous or compound heterozygous
form [9, 26]. The disease-causing mutation mechanism
of the missense mutation R91W is not yet known but has
already been reported as a recurrent mutation arising on
different ethnic backgrounds [26]. This change together
with the R91Q mutation was described as causing both
Leber congenital amaurosis (LCA) and autosomal re-
cessive retinitis pigmentosa in compound heterozygotes
and LCA in homozygotes [14, 18]. The R91W mutation
may exert its pathogenic effect by changing the tertiary
structure of the protein after the replacement of arginine,
a positively charged, linear strong proton donor, by
tryptophan, an uncharged aromatic proton donor [3].
Specifically, Thompson et al. predicted that the substi-
tution at arginine 91 may perturb the local beta-pleated
sheet structure into an alpha helix, possibly inactivating
a functional domain necessary for the synthesis of 11 cis-
retinal [26].
In our study of three nuclear families, we examined 53
members of whom 11 were affected, the larger series
described up to date with a single homozygous RPE65
mutation. Childhood visual function in homozygotes is
good enough to acquire reading in the first decade of life
but deteriorates to LP by the third decade of life. They all
had congenital nystagmus, night blindness and no photo-
phobia. Restricted visual field was common to all of them
and becomes non-testable by the third decade of life.
Colour vision could be evaluated by the Farnsworth
dichotomous D-15 test for the only patient in the second
decade, indicating an initial partial preservation of the cone
system. Only saturated red, green and blue colours could be
recognised by the third decade and none could be
distinguished by the fourth decade. All this findings
suggests that R91W phenotype is initially a rod–cone
dystrophy. Although visual function was reduced since
early childhood, the overall performance was better than
usually seen in LCA [4, 10]. Our findings are in keeping
with the previous phenotypical descriptions of RPE65
mutations in humans and dogs [2, 5, 19] but inconsistent
with findings reported in RPE65 knock-out mice [23]. One
possible explanation is that the survival time of cones
relates to the size of the organism, so that mice may lose
their cone functionality very early, whereas it is preserved
longer in dogs and humans.
Two retinal patterns in homozygotes emerged based on
fundus and fluorescein angiogram. Based on the work of
Moiseyev et al. [16], we postulate that the peripheral white
dot deposits seen on funduscopy of pattern 1 patients may
represent accumulation of retinyl esters in the RPE. Their
presence should be further assessed in other RPE65 gene
mutations. White dots and clumped pigment have been
described in other disease-causing mutations (mutations in
NR2E3, RLBP1, RDH5 genes) [17, 24, 27, 29]. The
significant difference in age between the two patterns
suggested that they may represent a continuum in the
evolution of the disease. All homozygous patients showed
a complete loss of ERG responses and an abnormal
pupillary reflex. However, a recordable reflex could be
obtained in some of the homozygotes, suggesting that
pupillometry may be one objective means of assessing and
monitoring visual function in these patients as well as in
patients who may benefit from future gene therapy [1]. In
contrast, heterozygous patients showed normal visual
function, ERG and pupillometry. Younger siblings should
be further identified and tested.
Early-onset rod–cone dystrophy along with white dot
deposits and typical absent or minimal autofluorescence, as
described by Lorenz et al. [13], may become extremely
Fig. 5 Single monocular recordings to light flash in two patients
(solid curve homozygote; dashed curve heterozygote)
1110
helpful criteria in the clinical diagnosis of RPE65
mutations.
In conclusion, we identified and characterised an
endemic form of early onset retinal dystrophy. It presents
as an early-onset rod–cone dystrophy in a highly inbred
population of Cap Bon in northeastern Tunisia, due to the
prevalence of a single homozygous missense R91W
mutation in exon 4 of the RPE65 gene, most likely caused
by a founder effect. Two patterns were identified: the white
dot deposits in earlier stages and the clumped pigment in
later stages may represent a continuum. Thorough pheno-
typing is likely to be of great assistance in identifying this
patients and will give guidance for future gene therapy.
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